Valuation: Bayer AG

Market Cap 48.25B 56.21B 45.28B 41.36B 78.06B 5,361B 78.43B 536B 208B 2,705B 211B 206B 8,959B P/E 2026 *
21.9x
P/E 2027 * 16x
Enterprise Value 78.2B 91.11B 73.4B 67.04B 127B 8,690B 127B 869B 337B 4,384B 342B 335B 14,521B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.08%
1 week+0.04%
Current month+2.03%
1 month+6.52%
3 months+30.10%
6 months+17.77%
Current year+32.86%
1 week 47.44
Extreme 47.445
49.92
1 month 45
Extreme 45
50.46
3 years 18.39
Extreme 18.39
53.9
5 years 18.39
Extreme 18.39
67.99
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%+0.04%+72.21%-1.85% 56.21B
-3.59%-7.10%+61.60%+114.83% 1,060B
-1.15%-1.25%+52.98%+62.41% 651B
-1.09%-1.15%+26.18%+79.22% 465B
-1.47%+0.24%+42.09%+42.09% 365B
-0.90%+0.05%+25.57%+41.75% 300B
-1.94%+1.53%+3.05%+13.24% 258B
-0.43%-0.46%+52.06%+71.75% 238B
-0.93%+1.84%-13.11%-52.28% 210B
-0.46%+0.33%+29.05%+92.67% 184B
Average -1.33%-0.66%+35.17%+46.38% 414.49B
Weighted average by Cap. -1.81%-2.16%+40.88%+66.94%

Financials

2026 *2027 *
Net sales 45.77B 53.33B 42.96B 39.24B 74.05B 5,087B 74.41B 508B 197B 2,566B 200B 196B 8,499B 47.01B 54.77B 44.12B 40.3B 76.05B 5,224B 76.42B 522B 202B 2,635B 206B 201B 8,729B
Net income 2.14B 2.49B 2.01B 1.83B 3.46B 237B 3.47B 23.73B 9.2B 120B 9.35B 9.14B 397B 2.94B 3.43B 2.76B 2.52B 4.76B 327B 4.78B 32.67B 12.66B 165B 12.87B 12.59B 546B
Net Debt 29.95B 34.9B 28.12B 25.68B 48.46B 3,329B 48.7B 333B 129B 1,679B 131B 128B 5,562B 26.83B 31.26B 25.18B 23B 43.41B 2,982B 43.62B 298B 115B 1,504B 117B 115B 4,982B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
26-08-26 €49.15 +0.11%
26-08-25 €49.10 +1.25%
26-08-24 €48.49 +1.44%
26-08-21 €47.80 -1.54%
26-08-20 €48.55 -1.18%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.11EUR
Average target price
57.39EUR
Spread / Average Target
+16.86%

Quarterly revenue - Rate of surprise